# Dyanavel XR

NDC: 24478-102
Generic name: amphetamine
Labeler / Manufacturer: NextWave Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20151001

FDA application: NDA208147

## Active ingredients

- AMPHETAMINE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24478-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24478-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae304b29-0b40-40ec-ad0d-76b742d4a9b9